相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RNA interference-mediated knockdown of SIRT1 and/or SIRT2 in melanoma: Identification of downstream targets by large-scale proteomics analysis
Melissa J. Wilking-Busch et al.
JOURNAL OF PROTEOMICS (2018)
The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
Shang Yao et al.
SEMINARS IN CANCER BIOLOGY (2018)
Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer
Regina Mora Vidal et al.
UROLOGY (2018)
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Youxiang Hou et al.
CELL DEATH & DISEASE (2017)
Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways
Lin Liu et al.
BMC CANCER (2016)
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma
Jared M. Weiss et al.
CANCER (2016)
HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK
Daphne Gschwantler-Kaulich et al.
PLOS ONE (2016)
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
Jean-Pascal H. Machiels et al.
LANCET ONCOLOGY (2015)
Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin
Jingjing Wu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma
Lizhu Jiang et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2014)
Final analysis: A randomized, blinded, placebo (P)-controlled phase III study of adjuvant postoperative lapatinib (L) with concurrent chemotherapy and radiation therapy (CH-RT) in high-risk patients with squamous cell carcinoma of the head and neck (SCCHN).
Kevin J. Harrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer
Mattaka Khongkow et al.
CARCINOGENESIS (2013)
Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
Yunbao Pan et al.
PLOS ONE (2013)
Forkhead box proteins: tuning forks for transcriptional harmony
Eric W. -F. Lam et al.
NATURE REVIEWS CANCER (2013)
SIRT2 activity is required for the survival of C6 glioma cells
Xin He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells
Lan Dan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin
Ka-Kei Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma
Zhu Shou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
C. T. Karadedou et al.
ONCOGENE (2012)
Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation
F. Wang et al.
ONCOGENE (2012)
A Global View of the Oncogenic Landscape in Nasopharyngeal Carcinoma: An Integrated Analysis at the Genetic and Expression Levels
Chunfang Hu et al.
PLOS ONE (2012)
C-KIT overexpression and mutation in nasopharyngeal carcinoma cell lines and reactivity of Imatinib on these cell lines
Pei-Yu Huang et al.
Chinese Journal of Cancer (2012)
The Extending Network of FOXO Transcriptional Target Genes
Kristan E. van der Vos et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy
Miranda S.C. Wilson et al.
CURRENT DRUG TARGETS (2011)
Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer
Yolanda Olmos et al.
DRUG RESISTANCE UPDATES (2011)
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells
Vivian Wai Yan Lui et al.
INVESTIGATIONAL NEW DRUGS (2011)
FoxM1 Mediates Resistance to Herceptin and Paclitaxel
Janai R. Carr et al.
CANCER RESEARCH (2010)
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Brigette B. Y. Ma et al.
INVESTIGATIONAL NEW DRUGS (2010)
SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Barrie Peck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Ursula B. McGovern et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction
Fei Wang et al.
AGING CELL (2007)
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Ji-Hye Paik et al.
CELL (2007)
A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer
Wenle Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-jun NH2-Terminal kinase and Akt
A Sunters et al.
CANCER RESEARCH (2006)
Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress
KF Chua et al.
CELL METABOLISM (2005)
Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells
N Matsushita et al.
GENES TO CELLS (2005)
Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells
BW Cheung et al.
CANCER RESEARCH (2005)
Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma
BBY Ma et al.
CANCER (2005)
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
A Brunet et al.
SCIENCE (2004)
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma - A prospective study
BBT Ma et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2003)
Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy
CH Hsu et al.
ONCOLOGY (2002)
分享论文
